Clover Health is trading 4.5% up at $4.76 as U.S. equities rebound following the Federal Reserve’s September 16 rate hike and easing policy uncertainty.

  • The broader rally is the clearest available explanation.
  • The S&P 500 is up 0.88%, while the Nasdaq is up 1.44%.
  • Recent interest around Humana’s Counterpart Health vendor list and healthcare conferences appears supportive but predates September 17.